Summary

United States Anesthesia Drugs Market size is predicted to reach to US$ 3.29 Billion by 2030, as per Renub Research. Anesthesia is the loss of feeling or sensation. It is often administered all through surgical approaches to save pain or soreness. Different medication can be used to set off anesthesia and bring about partial or whole loss of sensation. Anesthetic drugs are not commonly used outside of anesthesia, but many different types are utilized in cutting-edge anesthetic practice. While a few drugs are reserved totally for anesthesia, others are regularly used throughout different scientific disciplines. The anesthesiology industry comprises main factors: anesthesia and anesthesiologists. Many portions of device are specially designed for different surgical techniques. An Anesthetic Vaporizer is used for vaporizing anesthetic, nasal oxygen set for delivering oxygen, and many others.

Anesthesia is a critical component in almost all surgical processes nowadays, as it helps to numb the ache at during the operation. This type of medical treatment is gaining recognition inside the United States, in particular among those among 50 and 75 years old. The market for anesthesia medicines and devices in the US is experiencing significant increase due to different factors, which include the increasing variety of older adults, the upward push in monitored anesthesia use, the thriving in chronic diseases, and the volume of surgical procedures being accomplished. Over the few decades, the prevalence of cancers has also risen considerably within the US. According to the National Cancer Institute, there are currently round 16.9 million cancer survivors in the USA, a figure that is anticipated to rise to 22.2 million via the year 2030.


United States Anesthesia Drugs Market is expected to develop at a CAGR of 3.88% all through the 2024-2030

The demand for anesthesia medicines is rising because of the growing number of surgeries and the approval of recent anesthesia drugs. According to the American Society of Plastic Surgeons, a 3% growth in cosmetic surgical methods, minimally invasive strategies, and reconstructive processes performed in 2020, the United States witnessed an evaluation to the preceding year, with 2.3 Million cosmetic surgical methods, 3.2 million minimally invasive strategies, and 6.8 million reconstructive processes being carried out. As a result, the demand for anesthesia drugs has been growing.

The anesthesia market is anticipated to develop rapidly due to elevated product launches, strategic acquisitions, and government approvals in the USA. Heron Therapeutics, Inc.'s ZYNRELEF has received approval from Health Canada to provide postoperative pain comfort for surgical techniques including a bunionectomy, open inguinal herniorrhaphy, and total knee arthroplasty. Yet, the market faces particular demanding situations, such as the facet consequences of anesthesia, the high price of anesthesia device. United States Anesthesia Drugs Market turned into valued at US$ 2.52 Billion in 2023.


Local Anesthesia Drugs Market will have a large proportion in the United States Anesthesia Drugs Market

The United States Anesthesia Drugs Market is assessed into Inhalation Anesthesia, Intravenous Anesthesia, and Local Anesthesia. Local anesthesia drugs are predicted to enhance USA anesthesia drugs market growth drastically. They provide pain medicine, have moderate and rare aspect results, and are price-effective. Their management reduces the chance of aspiration pneumonia and allows patients to be discharged faster, making them a top-rated choice for medical doctors.


Sevoflurane is one of the maximums used general anesthetics in surgeries

The General Anesthesia Drugs Market is hastily advancing, specifically in the use of Sevoflurane, Desflurane, Isoflurane, and other inhalation anesthesia drugs. Sevoflurane, a broadly used drug for inducing and preserving anesthesia in the course of medical procedures, is know for its fast action and quick patient recovery. As the most usually type of anesthesia, sevoflurane, together with desflurane and nitrous oxide, leads the marketplace. Its low pungency, non-worrying smell, and low blood and gas partition coefficient contribute to its popularity. The sevoflurane segment anticipates widespread growth inside the US market, pushed with the aid of improved adoption, rising healthcare expenditure, and ongoing product launches.


Propofol captured the outmost share inside the General Intravenous Anesthesia Drugs market

The General Anesthesia Drugs market is classed into Propofol, Etomidate, Ketamine, & Barbiturates. Propofol has emerged as the dominant participant within the General Intravenous Anesthesia Drugs market. Its significant use is attributed to its extensive use onset smooth induction, and quick recovery, making it a favored preference for plenty anesthesia procedures. The drug's protection profile and efficacy have solidified its position, particularly in surgical and diagnostic settings. Propofol's popularity underscores its vital role in ensuring patient comfort and safety during in clinical approaches, establishing it as the frontrunner within the competitive landscape of General Intravenous Anesthesia Drugs.


Prilocaine Local Anesthesia Drugs market was observing significant growth

Local Anesthesia Drugs market is split into Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine, and Others. The market for Prilocaine Local Anesthesia Drugs has witnessed massive thriving, pushed through the growing demand for efficient local anesthesia solutions in numerous scientific and dental procedures. Prilocaine, known for its efficacy and safety, has received prominence among healthcare specialists. The Prilocaine Local Anesthesia Drugs market is booming because it keeps to satisfy meet the needs of patients and practitioners alike. This surge underscores the pivotal role of such drugs in improving patient comfort and facilitating scientific interventions, reinforcing Prilocaine's importance in the market.


Key Players Analysis

Baxter International Inc, Abbvie, Medtronic Plc, Draegerwerk AG, Koninklijke Philips NV, and Abbott Laboratories are the leading players in the United States Anesthesia Drugs Market.


Renub Research latest Report “United States Anesthesia Drugs Market by Type (General Inhalation Anesthesia Drugs market, General Intravenous Anesthesia Drugs Market and Local Anesthesia Drugs Market) by General Inhalation Anesthesia Drugs market (Sevoflurane, Desflurane, Isoflurane & Others) by General Intravenous Anesthesia Drugs Market (Propofol, Etomidate, Ketamine & Barbiturates) by Local Anesthesia Drugs Market (Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine & Other local anesthetics) by Company Analysis (Baxter International Inc, Abbvie, Medtronic Plc, Draegerwerk AG, Koninklijke Philips NV and Abbott Laboratories)” provides complete details on United States Anesthesia Drugs Market.


Type – United States Anesthesia Drugs Market breakup by 3 viewpoints

1. General Intravenous Anesthesia Drugs Market
2. General Inhalation Anesthesia Drugs Market
3. Local Anesthesia Drugs Market


General Intravenous Anesthesia Drugs Market breakup by 4 viewpoints

1. Propofol
2. Etomidate
3. Ketamine
4. Barbiturates


General Inhalation Anesthesia Drugs Market breakup by 4 viewpoints

1. Sevoflurane
2. Desflurane
3. Isoflurane
4. Others


Local Anesthesia Drugs Market breakup by 7 viewpoints

1. Bupivacaine
2. Ropivacaine
3. Lidocaine
4. Chloroprocaine
5. Prilocaine
6. Benzocaine
7. Other local Anesthetics


Reimbursement Policy – United States Anesthesia Drugs Market 2 viewpoint

A) Private Health Insurance Providers

1. Aetna International
2. Coventry Health Care
3. Anthem Blue Cross and Blue Shield
4. Blue Cross and Blue Shield of Texas
5. United Healthcare

B) Public Health Insurance Providers

1. Medicare
2. MDWise


All key players have been covered from 3 viewpoints

• Overview
• Recent Development
• Revenue


Company Analysis:

1. Baxter International Inc
2. Abbvie
3. Medtronic Plc
4. Draegerwerk AG
5. Koninklijke Philips NV
6. Abbott Laboratories

ページTOPに戻る

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. United States Anesthesia Drugs Market

6. Share Analysis – United States Anesthesia Drugs Market

6.1 Anesthesia Drugs
6.2 General Inhalation Anesthesia Drugs Market
6.3 General Intravenous Anesthesia Drugs
6.4 Local Anesthesia Drugs


7. Types – United States Anesthesia Drugs Market

7.1 General Inhalation Anesthesia Drugs Market
7.2 General Intravenous Anesthesia Drugs Market
7.3 Local Anesthesia Drugs Market


8. General Inhalation Anesthesia Drugs Market

8.1 Sevoflurane
8.2 Desflurane
8.3 Isoflurane
8.4 Others


9. General Intravenous Anesthesia Drugs Market

9.1 Propofol
9.2 Etomidate
9.3 Ketamine
9.4 Barbiturates


10. Local Anesthesia Drugs Market

10.1 Bupivacaine
10.2 Ropivacaine
10.3 Lidocaine
10.4 Chloroprocaine
10.5 Prilocaine
10.6 Benzocaine
10.7 Other local anesthetics


11. Merger & Acquisition (M&A) – United States Anesthesia

12. Reimbursement Policy – United States Anesthesia Drugs Market

12.1 Private Health Insurance Providers

12.1.1 Aetna International
12.1.2 Coventry Health Care
12.1.3 Anthem Blue Cross and Blue Shield
12.1.4 Blue Cross and Blue Shield of Texas
12.1.5 United Healthcare

12.2 Public Health Insurance Providers

12.2.1 Medicare
12.2.2 MDWise


13. Porter’s Five Forces – United States Anesthesia Drugs Market

13.1 Bargaining Power of Buyers
13.2 Bargaining Power of Suppliers
13.3 Degree of Rivalry
13.4 Threat of New Entrants
13.5 Threat of Substitutes


14. SWOT Analysis – United States Anesthesia Drugs Market

14.1 Strength
14.2 Weakness
14.3 Opportunity
14.4 Threat


15. Key Players Analysis

15.1 Baxter International Inc.

15.1.1 Overview
15.1.2 Recent Development
15.1.3 Revenue

15.2 Abbvie

15.2.1 Overview
15.2.2 Recent Development
15.2.3 Revenue

15.3 Medtronic Plc

15.3.1 Overview
15.3.2 Recent Development
15.3.3 Revenue

15.4 Draegerwerk AG

15.4.1 Overview
15.4.2 Recent Development
15.4.3 Revenue

15.5 Koninklijke Philips NV

15.5.1 Overview
15.5.2 Recent Development
15.5.3 Revenue

15.6 Abbott Laboratories

15.6.1 Overview
15.6.2 Recent Development
15.6.3 Revenue

ページTOPに戻る

List of Tables/Graphs

Table-01: United States – Anesthesia Drugs Market Share (Million US$), 2018 – 2023
Table-02: United States – Forecast for Anesthesia Drugs Market Share (Million US$), 2024 – 2030
Table-03: United States – General Inhalation Anesthesia Drugs Market Market Share (Million US$), 2018 – 2023
Table-04: United States – Forecast for General Inhalation Anesthesia Drugs Market Market Share (Million US$), 2024 – 2030
Table-05: United States – General Intravenous Anesthesia Drugs Market Share (Million US$), 2018 – 2023
Table-06: United States – Forecast for General Intravenous Anesthesia Drugs Market Share (Million US$), 2024 – 2030
Table-07: United States – Local Anesthesia Drugs Market Share (Million US$), 2018 – 2023
Table-08: United States – Forecast for Local Anesthesia Drugs Market Share (Million US$), 2024 – 2030